Company: ANIX
Filing Date: 2025-03-21
Form Type: 8-K
Source: 0001493152-25-011151
Chunk: 1

Company: Anixa Biosciences Inc
Filing Date: 2025-03-21
Form: 8-K
Item: Item 5.07
Chunk 1
---
, by non-binding advisory vote, was approved. The voting results were as follows:

  Votes For                     Votes Against                     Abstentions                   Broker Non-Votes                  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                 6,614,575                         3,364,480                       170,683                            10,541,515  

Proposal
No. 3 - Ratification of the appointment of independent registered public accounting firm

The
appointment of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending
October 31, 2025 was ratified. The voting results were as follows:

  Shares Voted For                      Shares Voted Against                   Shares Abstaining                   Broker Non-Vote  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                        19,941,654                                186,531                             563,068                       

Proposal
No. 4 - Approval, by non-binding advisory vote, on the frequency of advisory votes on the Company’s executive compensation

The
frequency of one year for future advisory votes on the Company’s executive compensation was approved by non-binding advisory vote.
The voting results were as follows:

  3 Years                     2 Years                   1 Year                     Abstentions               
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────
               1,058,421                   168,766                  8,735,450                       187,101  

Item 7.01 Regulation FD Disclosure.